Chosun University announced on May 19 that the Guard Cohort Research Group has been selected for the government’s 10 Global TOP Projects through a consortium with the Korea Institute of Oriental Medicine and the Korea Institute of Science and Technology (KIST).
The Ministry of Science and ICT and the National Research Council of Science & Technology (NST) have newly selected a total of 10 'Global TOP Strategic Research Groups' for 2025. Among these, the 'Next-Generation Brain Glymphatic System and Nervous System Regulation Strategic Research Group', in which the Chosun University Guard Cohort Research Group is participating, was selected.
This consortium will receive a total of 25 billion KRW in research funding over the next five years and will embark on the development of groundbreaking medical devices for the treatment of dementia and other age-related brain diseases.
The 'Global TOP Strategic Research Group Support Project' is a national strategic initiative aimed at producing world-class research results and securing technological sovereignty with a significant competitive edge, focusing on national missions. The consortium including Chosun University was selected as a future-challenge type research group among the total of 10 strategic research groups, which are classified into national strategy and future-challenge types, and will accelerate the development of treatments for degenerative brain diseases.
The 'Next-Generation Brain Glymphatic System and Nervous System Regulation Strategic Research Group (Strategic Research Group)' will develop innovative technologies to overcome age-related brain diseases by utilizing the brain glymphatic system, which has recently attracted significant attention.
The research group will specifically elucidate the changes in cerebrospinal fluid flow and waste clearance mechanisms resulting from stimulation of the brain glymphatic system, and plans to create the world’s first glymphatic map for humans. In particular, the Chosun University Degenerative Brain Disease Demonstration Research Group, which possesses Asia’s largest cohort of high-risk dementia patients and clinical experts, will collaborate with the Korea Institute of Oriental Medicine and KIST to comprehensively promote the entire cycle from technology development and clinical validation to device development and commercialization.
If the research progresses successfully, medical devices could be commercialized by 2030. This is expected to make a significant contribution to improving the quality of life and responding to the super-aged society in Korea, which now faces an era with one million dementia patients. In addition, this research is anticipated to become a key growth engine driving the future senior healthcare industry.
Lee Gunho, head of the Guard Cohort Research Group, stated, "Selection for the Global TOP Project is a recognition of Chosun University’s capabilities in medical big data and advanced research technologies." He added, "Through this project, we will address the challenges of a super-aged society and, based on Chosun University’s capabilities as a leader in glocal well-aging, take the lead in developing innovative medical technologies for the global market."
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
